Managing Stable Ischemic Heart Disease.
暂无分享,去创建一个
[1] Sean M. O'Brien,et al. Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease. , 2020, New England Journal of Medicine.
[2] Marco Valgimigli,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.
[3] G. Stone,et al. Medical Therapy With Versus Without Revascularization in Stable Patients With Moderate and Severe Ischemia: The Case for Community Equipoise. , 2016, Journal of the American College of Cardiology.
[4] Joseph Loscalzo,et al. Precision medicine in cardiology , 2016, Nature Reviews Cardiology.
[5] Sean M. O'Brien,et al. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design , 2018, American heart journal.
[6] P. F. Kauff. Group , 2000, Elegant Design.
[7] Sean M. O'Brien,et al. Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. , 2020, The New England journal of medicine.
[8] Sean M. O'Brien,et al. Management of Coronary Disease in Patients with Advanced Kidney Disease. , 2020, The New England journal of medicine.
[9] Sean M. O'Brien,et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. , 2020, The New England journal of medicine.
[10] D. Francis,et al. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease , 2020, Circulation. Cardiovascular quality and outcomes.
[11] Sean M. O'Brien,et al. Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial , 2019, JAMA cardiology.
[12] E. Braunwald,et al. Coronary-artery surgery at the crossroads. , 1977, The New England journal of medicine.